Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 119 of the 120 references it cites were found in a registry or an index, and 1 are not checked yet.

Genome-encoded ABCF factors implicated in intrinsic antibiotic resistance in Gram-positive bacteria: VmlR2, Ard1 and CplR

Open access

Abstract

Genome-encoded antibiotic resistance (ARE) ATP-binding cassette (ABC) proteins of the F subfamily (ARE-ABCFs) mediate intrinsic resistance in diverse Gram-positive bacteria. The diversity of chromosomally-encoded ARE-ABCFs is far from being fully experimentally explored. Here we characterise phylogenetically diverse genome-encoded ABCFs from Actinomycetia (Ard1 from Streptomyces capreolus, producer of the nucleoside antibiotic A201A), Bacilli (VmlR2 from soil bacterium Neobacillus vireti) and Clostridia (CplR from Clostridium perfringens, Clostridium sporogenes and Clostridioides difficile). We demonstrate that Ard1 is a narrow spectrum ARE-ABCF that specifically mediates self-resistance against nucleoside antibiotics. The single-particle cryo-EM structure of a VmlR2-ribosome complex allows us to rationalise the resistance spectrum of this ARE-ABCF that is equipped with an unusually long antibiotic resistance determinant (ARD) subdomain. We show that CplR contributes to intrinsic pleuromutilin, lincosamide and streptogramin A resistance in Clostridioides, and demonstrate that C. difficile CplR (CDIF630_02847) synergises with the transposon-encoded 23S ribosomal RNA methyltransferase Erm to grant high levels of antibiotic resistance to the C. difficile 630 clinical isolate. Finally, assisted by uORF4u, our novel tool for detection of upstream open reading frames, we dissect the translational attenuation mechanism that controls the induction of cplR expression upon an antibiotic challenge.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/nar/gkad193

Cites

119 of 120 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Maximum likelihood phylogenetic analysis of selected ABCFs places CplR, Ard1 and VmlR2 in different clades of the ABCF family tree. (A) Branches are proportional to the number of amino acid substitutions according to the lower left legend. Branch support values are percentage Ultrafast Bootstrap Support values, in percentages. Only those 50% or higher are shown. CplR is a member of the ARE1 subfamily, but without any strongly supported specific association with Vga or Msr subtypes. There is strong support for Ard1 falling within the same clade as other actinomycete ARE subfamilies, all of which likely confer self-protection of the antibiotic producer. VmlR2 is a close relative of VmlR, but has distinctive sequence/structure features, including (B) an extended ARD/linker subdomain (see Supplementary Figure S4 for full alignment).
Figure 1. Maximum likelihood phylogenetic analysis of selected ABCFs places CplR, Ard1 and VmlR2 in different clades of the ABCF family tree. (A) Branches are proportional to the number of amino acid substitutions according to the lower left legend. Branch support values are percentage Ultrafast Bootstrap Support values, in percentages. Only those 50% or higher are shown. CplR is a member of the ARE1 subfamily, but without any strongly supported specific association with Vga or Msr subtypes. There is strong support for Ard1 falling within the same clade as other actinomycete ARE subfamilies, all of which likely confer self-protection of the antibiotic producer. VmlR2 is a close relative of VmlR, but has distinctive sequence/structure features, including (B) an extended ARD/linker subdomain (see Supplementary Figure S4 for full alignment).CC BY · PubMed Central
Figure 2. Cryo-EM structure of N. vireti VmlR2-EQ2 bound to the 70S ribosome. (A) Overview of cryo-EM density containing the large ribosomal subunit (grey), VmlR2 (brown), and the small ribosomal subunit (yellow). (B) As for (A), except the large ribosomal subunit is shown as an outline only. A distorted P-tRNA is coloured cyan, and a substoichiometric A-tRNA is pink. (C) Isolated density and model of VmlR2 only. The model is coloured by domain, with ATPs coloured red. Non-sharpened maps are shown. (D) View of P- and A-tRNAs poised for peptidyl transfer in the PTC (pre-attack state, PDB ID 1VY4, (113)). The position of lincomycin is superimposed (PDB ID 8A5I, (114)). (E) Same view as D but showing the VmlR2 (brown) and B. subtilis VmlR (transparent, orange, PDB ID 6HA8, (34)) interdomain linkers. A dashed circle indicates the site of PLSA binding. Distorted P-tRNAs are shown in cyan, and a dashed line indicates the approximate path of the tRNA CCA-3′ end, which was not modelled. (F) Close view of the VmlR2 ARD reaching into the PTC. Ile261 is predicted to clash with superimposed lincomycin (PDB ID 8A5I). Van der Waals radii of the two closest atoms are shown as semi-transparent spheres, with a red line indicating a clash between them. (G) VmlR2 Y223 forms a stacking interaction with U2585. (H) View of PL2 forming part of the lincomycin binding site with 23S rRNA nucleotides shown in cyan (PDB ID 8A5I). (I) Same as H but with VmlR2 superimposed. 23S rRNA nucleotides from the VmlR2-bound structure are shown in grey. Models were aligned by 23S rRNA.
Figure 2. Cryo-EM structure of N. vireti VmlR2-EQ2 bound to the 70S ribosome. (A) Overview of cryo-EM density containing the large ribosomal subunit (grey), VmlR2 (brown), and the small ribosomal subunit (yellow). (B) As for (A), except the large ribosomal subunit is shown as an outline only. A distorted P-tRNA is coloured cyan, and a substoichiometric A-tRNA is pink. (C) Isolated density and model of VmlR2 only. The model is coloured by domain, with ATPs coloured red. Non-sharpened maps are shown. (D) View of P- and A-tRNAs poised for peptidyl transfer in the PTC (pre-attack state, PDB ID 1VY4, (113)). The position of lincomycin is superimposed (PDB ID 8A5I, (114)). (E) Same view as D but showing the VmlR2 (brown) and B. subtilis VmlR (transparent, orange, PDB ID 6HA8, (34)) interdomain linkers. A dashed circle indicates the site of PLSA binding. Distorted P-tRNAs are shown in cyan, and a dashed line indicates the approximate path of the tRNA CCA-3′ end, which was not modelled. (F) Close view of the VmlR2 ARD reaching into the PTC. Ile261 is predicted to clash with superimposed lincomycin (PDB ID 8A5I). Van der Waals radii of the two closest atoms are shown as semi-transparent spheres, with a red line indicating a clash between them. (G) VmlR2 Y223 forms a stacking interaction with U2585. (H) View of PL2 forming part of the lincomycin binding site with 23S rRNA nucleotides shown in cyan (PDB ID 8A5I). (I) Same as H but with VmlR2 superimposed. 23S rRNA nucleotides from the VmlR2-bound structure are shown in grey. Models were aligned by 23S rRNA.CC BY · PubMed Central
Figure 3. Nucleotide sequence and predicted secondary structures of the 5′ leader region of cplR mRNA in induced and repressed conformations. (A) dRNA-seq (sampled in late exponential or stationary phase) and RNAtag-seq reads for annotation of transcriptional start sites (TSSs) and termination sites (TTSs), respectively, mapped to 5′ upstream region (CDIF630nc_084) preceding the cplR ORF (CDIF630_02847) (54). (B) Alignments of 5′ upstream regions elements in Clostridial CplRs and L. monocytogenes Lmo0919/VgaL focused on the uORF and anti-Shine-Dalgarno (anti-SD) elements. (C–F) Consensus sequences for (C) CplR, (D) VmlR, (E) VmlR2 and (F) LsaA uORF elements. The full uORF peptide alignments are shown in Supplementary Table 3. (G and H) Predicted secondary structure of cplR mRNA 5′ leader region in repressed (G, in the absence of antibiotic-induced ribosomal stalling on the uORF(MRI)) and induced (H, in the presence of ribosomal stalling). Substitutions that were used for experimental probing the key functional elements are shown in red.
Figure 3. Nucleotide sequence and predicted secondary structures of the 5′ leader region of cplR mRNA in induced and repressed conformations. (A) dRNA-seq (sampled in late exponential or stationary phase) and RNAtag-seq reads for annotation of transcriptional start sites (TSSs) and termination sites (TTSs), respectively, mapped to 5′ upstream region (CDIF630nc_084) preceding the cplR ORF (CDIF630_02847) (54). (B) Alignments of 5′ upstream regions elements in Clostridial CplRs and L. monocytogenes Lmo0919/VgaL focused on the uORF and anti-Shine-Dalgarno (anti-SD) elements. (C–F) Consensus sequences for (C) CplR, (D) VmlR, (E) VmlR2 and (F) LsaA uORF elements. The full uORF peptide alignments are shown in Supplementary Table 3. (G and H) Predicted secondary structure of cplR mRNA 5′ leader region in repressed (G, in the absence of antibiotic-induced ribosomal stalling on the uORF(MRI)) and induced (H, in the presence of ribosomal stalling). Substitutions that were used for experimental probing the key functional elements are shown in red.CC BY · PubMed Central
Figure 4. cplR expression is de-repressed in C. difficile upon retapamulin or lincomycin challenge and re-repressed once the bacterial growth recovers. (A) Experimental setup used for cplR mRNA detection by RT-PCR using primers specific for cplR 5′ leader region, cplR ORF and fdxA ORF. (B) cplR mRNA accumulates in a dose-dependent manner in response to the addition of increasing concentrations of either retapamulin or lincomycin. The antibiotics were added to logarithmic phase C. difficile 630 ΔermR cultures of and total RNA collected 2 h after the antibiotic challenge. 23S and 16S rRNA were used as loading controls. (C) Kinetics of cplR mRNA accumulation in response to a sub-MIC challenge with retapamulin (200 ng/ml) or lincomycin (2 μg/ml). (Left) cplR 5′ leader region, cplR ORF and fdxA ORF were probed by RT-PCR amplification. (Right) Growth kinetics of C. difficile in the absence or presence of sub-MIC concentrations of retapamulin (200 ng/ml) or lincomycin (2 μg/ml). The time point of antibiotic addition is set as zero on the time axis.
Figure 4. cplR expression is de-repressed in C. difficile upon retapamulin or lincomycin challenge and re-repressed once the bacterial growth recovers. (A) Experimental setup used for cplR mRNA detection by RT-PCR using primers specific for cplR 5′ leader region, cplR ORF and fdxA ORF. (B) cplR mRNA accumulates in a dose-dependent manner in response to the addition of increasing concentrations of either retapamulin or lincomycin. The antibiotics were added to logarithmic phase C. difficile 630 ΔermR cultures of and total RNA collected 2 h after the antibiotic challenge. 23S and 16S rRNA were used as loading controls. (C) Kinetics of cplR mRNA accumulation in response to a sub-MIC challenge with retapamulin (200 ng/ml) or lincomycin (2 μg/ml). (Left) cplR 5′ leader region, cplR ORF and fdxA ORF were probed by RT-PCR amplification. (Right) Growth kinetics of C. difficile in the absence or presence of sub-MIC concentrations of retapamulin (200 ng/ml) or lincomycin (2 μg/ml). The time point of antibiotic addition is set as zero on the time axis.CC BY · PubMed Central
Figure 5. The ribosomal stalling on the uORF but not the premature RNAP termination is essential for induction of cplR in response to antibiotic challenge. (A) Experimental setup used for mutational probing of the cplR 5′ leader region. Fluorescent reporters relied on mCherry expression driven by the cplR promotor (PCplR) using wither (i) wild-type cplR 5′ leader, (ii) fdxA 5′ leader (5′ leaderfdxA), (iii–v) cplR 5′ leader with substitutions in the uORF start codon (mutuORF), the intrinsic terminator stem (muttermSL) or the polyU track downstream of the intrinsic terminator stem loop (mutpolyU). Locations of the substitutions on the mRNA secondary structure are presented on Figure 3CD. (B) Accumulation mCherry mRNA variants with different cplR 5′ leaders in response to a sub-MIC challenge with lincomycin (2 μg/ml). The antibiotics were added to the logarithmic phase of C. difficile 630 ΔermR culture and total RNA was collected 30 mins after the antibiotic challenge. mCherry ORF and fdx ORF were probed by RT-PCR amplification. 23S rRNA was used as loading control. (C and D) Mutational probing of the cplR 5′ leader. Expression of mCherry driven by is 5′ leaderfdxA (Pfdx-mCherry) is insensitive to sub-MIC challenge with retapamulin (C) or lincomycin (D). Wild-type PcplR-mCherry reporter is induced by both retapamulin (C) and lincomycin (D), though the signal is much lower than in the case of Pfdx-mCherry. The muttermSL reporter is constitutively induced and is insensitive to addition of either retapamulin (C) or lincomycin (D). The mutpolyU reporter is repressed in the absence of antibiotics and is induced by the retapamulin challenge (C). To calculate the relative promoter activity, relative fluorescence intensity normalised by O.D.600 was further normalised by the signal from the constitutive Pfdx-mCherry reporter.
Figure 5. The ribosomal stalling on the uORF but not the premature RNAP termination is essential for induction of cplR in response to antibiotic challenge. (A) Experimental setup used for mutational probing of the cplR 5′ leader region. Fluorescent reporters relied on mCherry expression driven by the cplR promotor (PCplR) using wither (i) wild-type cplR 5′ leader, (ii) fdxA 5′ leader (5′ leaderfdxA), (iii–v) cplR 5′ leader with substitutions in the uORF start codon (mutuORF), the intrinsic terminator stem (muttermSL) or the polyU track downstream of the intrinsic terminator stem loop (mutpolyU). Locations of the substitutions on the mRNA secondary structure are presented on Figure 3CD. (B) Accumulation mCherry mRNA variants with different cplR 5′ leaders in response to a sub-MIC challenge with lincomycin (2 μg/ml). The antibiotics were added to the logarithmic phase of C. difficile 630 ΔermR culture and total RNA was collected 30 mins after the antibiotic challenge. mCherry ORF and fdx ORF were probed by RT-PCR amplification. 23S rRNA was used as loading control. (C and D) Mutational probing of the cplR 5′ leader. Expression of mCherry driven by is 5′ leaderfdxA (Pfdx-mCherry) is insensitive to sub-MIC challenge with retapamulin (C) or lincomycin (D). Wild-type PcplR-mCherry reporter is induced by both retapamulin (C) and lincomycin (D), though the signal is much lower than in the case of Pfdx-mCherry. The muttermSL reporter is constitutively induced and is insensitive to addition of either retapamulin (C) or lincomycin (D). The mutpolyU reporter is repressed in the absence of antibiotics and is induced by the retapamulin challenge (C). To calculate the relative promoter activity, relative fluorescence intensity normalised by O.D.600 was further normalised by the signal from the constitutive Pfdx-mCherry reporter.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 117 references

Cited by

See all 42

Metadata

Authors
Obana, N., Takada, H., Crowe-McAuliffe, C., Iwamoto, M., Egorov, A. A., Wu, K. J. Y., Chiba, S., Murina, V., Paternoga, H., Tresco, B. I. C., Nomura, N., Myers, A. G., Atkinson, G. C., Wilson, D. N., & Hauryliuk, V.
Affiliations
  • University of Tsukuba (JP)
  • Kyoto Sangyo University (JP)
  • Institute for Biochemistry and Molecular Biology, University of Hamburg , Martin-Luther-King-Platz 6, 20146  Hamburg , Germany
  • Lund University (SE)
  • Harvard University (US)
  • Umeå University (SE)
  • Universität Hamburg (DE)
Corresponding author
  • Obana, Nozomu
  • Wilson, Daniel N
  • Hauryliuk, Vasili
Venue
Nucleic Acids Research
Published
2023-03-23
Volume
51
Issue
9
Pages
4536-4554
ISSN
  • 0305-1048 (ISSN-L)
  • 1362-4962
OpenAlex
W4353112026
Cited by
42
References
117
Citations by year
2026: 11 · 2025: 11 · 2024: 12 · 2023: 7
FWCI
3.50
Type
journal article
Language
en
Open access
Locations
  • Nucleic Acids Research (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DiVA at Umeå University (Umeå University) (submittedVersion, other-oa)
  • Lund University Publications (Lund University) (submittedVersion)
Funders
  • DFG (WI3285/8-1)
  • Swedish Research Council (2019-01085, 2017-03783, 2021-01146, 2018-00956)
  • Estonian Research Council (PRG335)
  • National Institutes of Health (R01AI168228)
  • Centre of Excellence in Molecular Cell Engineering (2014-2020.4.01.15-0013)
  • Deutsche Zentrum für Luft- und Raumfahrt (DLR01Kl1820)
  • Knut and Alice Wallenberg Foundation (2020-0037)
  • Scientific Research (20H05926, 21K06053, 21K07018)
  • Institute for Fermentation, Osaka (G-2021-2-063)
Topics
  • Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
Keywords
intrinsic antibiotic resistance, ARD1, Clostridium difficile, Clostridium perfringens, Clostridium sporogenes, pleuromutilin resistance, lincosamide resistance, translational attenuation, ribosome-associated proteins, cryo-EM structure, Gram-positive bacteria
MeSH terms
Anti-Bacterial Agents, Bacterial Proteins, Clostridium, Genes, Bacterial, Gram-Positive Bacteria, Methyltransferases, Nucleosides, Clostridioides difficile, Cryoelectron Microscopy, Drug Resistance, Bacterial, Actinobacteria

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Genome-encoded ABCF factors implicated in intrinsic antibiotic resistance in Gram-positive bacteria: VmlR2, Ard1 and CplR. https://app.cochat.ai/papers/10.1093/nar/gkad193
The paper
Obana, N., Takada, H., Crowe-McAuliffe, C., Iwamoto, M., Egorov, A. A., Wu, K. J. Y., Chiba, S., Murina, V., Paternoga, H., Tresco, B. I. C., Nomura, N., Myers, A. G., Atkinson, G. C., Wilson, D. N., & Hauryliuk, V. (2023). Genome-encoded ABCF factors implicated in intrinsic antibiotic resistance in Gram-positive bacteria: VmlR2, Ard1 and CplR. Nucleic Acids Research. https://doi.org/10.1093/nar/gkad193

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.